Literature DB >> 22227646

More trials are cut short, but not the debate over their trajectory.

Madhumita Venkataramanan.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22227646     DOI： 10.1038/nm0112-4a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Stopping a trial early in oncology: for patients or for industry?

Authors:  F Trotta; G Apolone; S Garattini; G Tafuri
Journal:  Ann Oncol       Date:  2008-02-27       Impact factor: 32.976

Review 2.  Early stopping rules in oncology: considerations for clinicians.

Authors:  Som D Mukherjee; John R Goffin; Valerie Taylor; Kelly K Anderson; Gregory R Pond
Journal:  Eur J Cancer       Date:  2011-06-16       Impact factor: 9.162

3.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.